Specialty Generics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 28
SKU : PH4061
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy
Request new version
What is the Projected CAGR value of the Specialty Generics Market?
Specialty Generics Market is expected to grow at a CAGR of 9.1% during the forecasting period 2024-2031.
Who are the major players in the specialty generics market?
The major players in the specialty generics market include Mylan N.V., Teva Pharmaceuticals USA, Inc., Sandoz International GmbH, Mallinckrodt, Akorn, Inc., Valeant Pharmaceuticals International, Inc., Endo Pharmaceuticals, Inc., Pfizer, Inc., Sun Pharmaceutical Industries Ltd, and Apotex Corp.